Skip to main content
CBIO
NASDAQ Life Sciences

Crescent Biopharma Prices $125M Public Offering at $14.50, a 5.3% Discount

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$15.305
Mkt Cap
$421.988M
52W Low
$8.72
52W High
$27.41
52W Position info
76% above low
Off High info
44% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

CBIO sits 76% above its 52-week low of $8.72 on light trading volume (0.2× avg).

Summary

Crescent Biopharma priced its public offering of 8,094,793 ordinary shares plus pre-funded warrants for 525,897 shares at $14.50 per share, a 5.3% discount to the last close of $15.305. Gross proceeds are expected to be $125 million, with an additional 30-day underwriter option for nearly 1.3 million shares. The offering is set to close July 16, following the July 14 launch announcement and the July 1 $500 million shelf filing. The discount and dilution are modest relative to the $422 million market cap, but the raise signals ongoing cash needs amid a $17.6 million quarterly burn rate. The company had $171.6 million in cash at end of Q2, so this extends runway significantly. The deal is backed by a strong syndicate including Jefferies and TD Cowen.

At the time of this announcement, CBIO was trading at $15.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $422M. The 52-week trading range was $8.72 to $27.41. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CBIO - Latest Insights

CBIO
Nov 12, 2026, 4:15 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $14.37
Real-time Price: $14.15 info
Change: -$0.220 (-2%) info
Market Cap: $550.371M info
CBIO
Nov 12, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.37
Real-time Price: $14.15 info
Change: -$0.220 (-2%) info
Market Cap: $550.371M info
CBIO
Oct 15, 2026, 4:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.47
Real-time Price: $14.15 info
Change: +$1.68 (+13%) info
Market Cap: $550.371M info
CBIO
Oct 05, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $14.91
Real-time Price: $14.15 info
Change: -$0.760 (-5%) info
Market Cap: $550.371M info
CBIO
Jul 30, 2026, 9:25 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.77
Real-time Price: $14.15 info
Change: -$0.620 (-4%) info
Market Cap: $550.371M info